Galza-Met Tablet 50mg / 500mg

About Galza-Met Tablet 50mg / 500mg

Galza-Met Tablet Uses

• Type 2 diabetes mellitus in adults
• Blood sugar control when diet and exercise alone are not enough
• Combination therapy that pairs vildagliptin with metformin in one tablet
• Add-on treatment for patients not controlled on metformin alone

Galza-Met Tablet Benefits

• Lowers fasting and post-meal blood glucose levels
• Improves insulin sensitivity and reduces liver glucose output
• Simplifies treatment by combining two diabetes medicines in one tablet
• Supports better HbA1c control with consistent daily dosing
• Carries a lower hypoglycemia risk compared to sulfonylureas

What Experts Say

Vildagliptin belongs to the DPP-4 inhibitor class of oral antidiabetics. It blocks the enzyme that breaks down incretin hormones such as GLP-1 and GIP. This keeps insulin secretion active after meals and reduces glucagon release from the pancreas, which lowers post-meal blood sugar spikes without a high risk of hypoglycemia.

Metformin works through a different pathway as a biguanide. It reduces glucose production in the liver and improves how muscle and fat tissue respond to insulin. This action lowers overall blood sugar levels without triggering excess insulin release, which keeps hypoglycemia risk low when the drug is used on its own.

Combining both drugs targets two separate mechanisms behind high blood sugar in type 2 diabetes. Physicians often prescribe this fixed-dose combination when metformin alone fails to reach target HbA1c levels. The dual action supports steadier fasting and post-meal glucose control while keeping the daily pill count low.

Drug Class

• DPP-4 Inhibitor and Biguanide Combination (Oral Antidiabetic)

Galza-Met Tablet 50mg / 500mg formula

• Vildagliptin 50mg + Metformin 500mg

Available forms

• Tablet

How to use Galza-Met Tablet 50mg / 500mg?

• Galza-Met Tablet should be taken exactly as prescribed by your doctor.
• The tablet should be swallowed whole with a full glass of water.
• Doses are usually taken with meals to reduce stomach upset.
• The tablet should not be crushed or chewed before swallowing.
• Doses should be taken at the same times each day for steady blood sugar control.
• The medicine should not be stopped without consulting your doctor first.

Drug Interactions

• Insulin: Increases the risk of hypoglycemia when combined with Galza-Met.
• Sulfonylureas: Combined use raises the chance of low blood sugar episodes.
• Corticosteroids: May reduce the blood sugar lowering effect of this medicine.
• Diuretics: Can affect kidney function and slow metformin clearance.
• ACE Inhibitors: May enhance the glucose lowering effect and raise hypoglycemia risk.
• Iodinated Contrast Media: Combined use raises the risk of lactic acidosis and kidney injury.
• Alcohol: Increases the risk of lactic acidosis and low blood sugar.

Risks and warnings

• Hypoglycemia: Low blood sugar risk rises when combined with insulin or sulfonylureas.
• Lactic Acidosis: Rare but serious risk from the metformin component, especially with kidney or liver impairment.
• Kidney Function: Not recommended for patients with severe renal impairment.
• Pancreatitis: Vildagliptin has been linked to rare cases of acute pancreatitis.
• Liver Disease: Avoid use in patients with active liver disease or elevated liver enzymes.
• Pregnancy And Breastfeeding: Not recommended unless clearly advised by a doctor.
• Surgery Or Contrast Dye: Temporary discontinuation may be needed before procedures using iodinated contrast.

Galza-Met Tablet Side Effects

• Nausea
• Diarrhea
• Stomach pain
• Loss of appetite
• Headache
• Dizziness
• Metallic taste in mouth
• Vitamin B12 deficiency with long term use
• Mild tremors
• Joint pain
• Skin rash or itching
• Fatigue

Storage Conditions

• Store below 30°C in a cool, dry place.
• Keep the tablet strip in its original packaging away from moisture.
• Protect from direct sunlight and humidity.
• Keep out of reach of children.
• Discard the tablet after the expiry date printed on the pack.